购物车
0
有库存
HIT214308203
 sdf 文件
结构编辑
类似物检索
HIT214308203
  • HIT ID:HIT214308203
  • Cas No:4043-88-3
  • 常用名:3,4-Dehydro-L-proline
  • IUPAC:(2S)-2,5-dihydro-1H-pyrrole-2-carboxylic acid
    IUPAC:(2S)-2,5-dihydro-1H-pyrrole-2-carboxylic acid
  • InChI key:OMGHIGVFLOPEHJ-BYPYZUCNSA-N
  • 分子式:C5H7NO2
  • 分子量:113.116
  • 氢键供体数 (HBD):
  • 氢键受体数 (HBA):
  • LogP:
  • SMILES:OC(=O)[C@H]1NCC=C1
    SMILES:OC(=O)[C@H]1NCC=C1
  • The leguminous shrub,Leucaena leucocephala(Leucaena) is wide‐spread in tropical and subtropical agricultural systems and provides a ready source of protein for livestock. However, the presence of mimosine, a non‐protein, amino acid comprising about 12% of the dry matter in growing tips ofLeucaena, is toxic to animals. Mimosine is degraded rapidly in the rumen to produce 3,4‐dihydroxypyridine (3,4‐DHP) and 2,3‐dihydroxypyridine (2,3‐DHP), both of which remain toxic to animals[1]. 3,4-DHP, as a derivative of the plant amino acid mimosine, is goitrogenic in cattle, sheep, and mice. In contrast to established antithyroid compounds, such as methimazole (MMI) and propylthiouracil (PTU), 3,4-DHP has no SH-group. 3,4-DHP with various concentrations inhibited incorporation of125I into protein in human thyroid slices. It also suppressed the activation of lymphocytes by PHA (phytohaemagglutinin) and PWM (pokeweed mitogen). Suppression with 3,4-DHP was seen at 100 and 1000 μmol/L (P< 0.001 vs both PHA and PWM). Those, together with a very low murine bone marrow toxicity, probably related to the absence of an SH-group, make 3,4-DHP a potential antithyroid drug[2].
市场产品/服务共显示3个结果
  • 供应商
    TargetMolSC
    规格
    货期
    5日内发货
    纯度
    -
    ¥ 1,133.00
    1
  • 供应商
    PharmaBlockBB
    规格
    货期
    4-7周
    纯度
    -
    待询
    1
  • 供应商
    BIONET-Key OrganicsBB
    规格
    货期
    4-6周
    纯度
    -
    ¥ 2,693.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~